ACST logo

Acasti Pharma (ACST) Return On Equity

Annual ROE

-20.82%
+41.62%+66.66%

31 March 2024

ACST ROE Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly ROE

-19.19%
-1.06%-5.85%

30 September 2024

ACST Quarterly ROE Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

ACST ROE Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+66.7%+64.8%
3 y3 years+63.7%-8.6%
5 y5 years+95.4%+98.1%

ACST ROE High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 years-129.6%+66.7%-89.1%+67.4%
5 y5 years-129.6%+95.4%-180.1%+98.1%
alltimeall time-343.9%+95.4%-105.4%+98.1%

Acasti Pharma ROE History

DateAnnualQuarterly
Sept 2024
-
-19.19%(+5.8%)
June 2024
-
-18.13%(-9.3%)
Mar 2024
-20.82%(-66.7%)
-19.99%(-66.0%)
Dec 2023
-
-58.88%(+8.0%)
Sept 2023
-
-54.53%(+6.9%)
June 2023
-
-51.00%(+11.0%)
Mar 2023
-62.44%(+588.4%)
-45.96%(+172.9%)
Dec 2022
-
-16.84%(+4.1%)
Sept 2022
-
-16.17%(+57.8%)
June 2022
-
-10.25%(+1.0%)
Mar 2022
-9.07%(-84.2%)
-10.15%(-26.6%)
Dec 2021
-
-13.83%(-21.7%)
Sept 2021
-
-17.67%(-65.0%)
June 2021
-
-50.46%(-41.4%)
Mar 2021
-57.33%(-73.0%)
-86.10%(-459.2%)
Dec 2020
-
23.97%(-120.4%)
Sept 2020
-
-117.43%(-77.1%)
June 2020
-
-513.91%(-16.3%)
Mar 2020
-212.26%(-53.1%)
-614.35%(-33.6%)
Dec 2019
-
-925.05%(-7.9%)
Sept 2019
-
-1004.50%(+40.3%)
June 2019
-
-715.75%(+20.8%)
Mar 2019
-452.14%(+207.4%)
-592.35%(+27.8%)
Dec 2018
-
-463.36%(-32.9%)
Sept 2018
-
-690.81%(+248.2%)
June 2018
-
-198.40%(+42.5%)
Mar 2018
-147.08%(+217.1%)
-139.20%(+57.7%)
Dec 2017
-
-88.27%(+44.8%)
Sept 2017
-
-60.95%(+27.2%)
June 2017
-
-47.91%
DateAnnualQuarterly
Mar 2017
-46.39%(+132.1%)
-
Nov 2016
-
-40.04%(+11.8%)
Aug 2016
-
-35.81%(+23.6%)
May 2016
-
-28.97%(+44.6%)
Feb 2016
-19.99%(+326.2%)
-20.04%(-1.7%)
Nov 2015
-
-20.39%(+468.0%)
Aug 2015
-
-3.59%(-69.8%)
May 2015
-
-11.87%(+148.3%)
Feb 2015
-4.69%(-91.1%)
-4.78%(-5.3%)
Nov 2014
-
-5.05%(-82.7%)
Aug 2014
-
-29.11%(-12.3%)
May 2014
-
-33.20%(-44.6%)
Feb 2014
-52.96%(-5.4%)
-59.96%(-20.4%)
Nov 2013
-
-75.28%(+11.4%)
Aug 2013
-
-67.58%(+3.6%)
May 2013
-
-65.26%(+18.3%)
Feb 2013
-55.98%(-12.7%)
-55.15%(+6.2%)
Nov 2012
-
-51.92%(-12.2%)
Aug 2012
-
-59.12%(-5.3%)
May 2012
-
-62.41%(-6.2%)
Feb 2012
-64.15%(+2.7%)
-66.57%(-25.2%)
Nov 2011
-
-89.02%(+3.6%)
Aug 2011
-
-85.94%(-41.8%)
May 2011
-
-147.75%(-141.5%)
Feb 2011
-62.45%(+66.4%)
356.13%(+112.6%)
Nov 2010
-
167.52%(+63.2%)
Aug 2010
-
102.64%(-35.4%)
May 2010
-
158.83%(-138.1%)
Feb 2010
-37.54%
-417.17%(-1371.5%)
Nov 2009
-
32.81%

FAQ

  • What is Acasti Pharma annual return on equity?
  • What is the all time high annual ROE for Acasti Pharma?
  • What is Acasti Pharma annual ROE year-on-year change?
  • What is Acasti Pharma quarterly return on equity?
  • What is the all time high quarterly ROE for Acasti Pharma?
  • What is Acasti Pharma quarterly ROE year-on-year change?

What is Acasti Pharma annual return on equity?

The current annual ROE of ACST is -20.82%

What is the all time high annual ROE for Acasti Pharma?

Acasti Pharma all-time high annual return on equity is -4.69%

What is Acasti Pharma annual ROE year-on-year change?

Over the past year, ACST annual return on equity has changed by +41.62% (+66.66%)

What is Acasti Pharma quarterly return on equity?

The current quarterly ROE of ACST is -19.19%

What is the all time high quarterly ROE for Acasti Pharma?

Acasti Pharma all-time high quarterly return on equity is 356.13%

What is Acasti Pharma quarterly ROE year-on-year change?

Over the past year, ACST quarterly return on equity has changed by +35.34% (+64.81%)